Profile: BioMarker Strategies is a cancer diagnostics company developing SnapPath™ live-tumor-cell biomarker testing system to improve the treatment of cancer. Our SnapPath™ is an automated system designed to help pathologists & oncologists predict patient response to chemotherapies & targeted cancer therapeutics, reduce unnecessary surgical biopsies and to obtain information on treatment options that are not available using current tumor-cell processing methods. Our SnapPath™ system is designed to enable the ex vivo manipulation of live tumor samples at the point of patient care where tumor cells are exposed to stimuli, such as growth factors, to evoke a biological response within the live tumor cell.